Samhitha J1*, Anilkumar KV1, Nagaraju B1, Shekar HS1, Neerajraj GN2, Padmavathi GV2
1Visveswarapura Institute of Pharmaceutical Sciences, BSK-2nd Stage, Bengaluru - 560070.
2UG-Medical, ESIC Medical College & PGIMSR, Rajajinagar, Bengaluru - 560010.
3Dept. of Medical Surgical Nursing, Aditya College of Nursing, Kogilu, Bengaluru - 560064.
*Corresponding Author E-mail: samhitha27@gmail.com
ABSTRACT:
Morinda citrifolia L., commonly known as noni, is a humid plant commonly used in traditional medicine across Polynesia, Southeast Asia, and parts of India. Noni fruit juice has gained global attention as a nutraceutical due to its reported antioxidant, anti-inflammatory, immunomodulatory, antimicrobial, metabolic, and anticancer properties. This review compiles and critically evaluates available scientific literature on the phytochemical composition, biological activities, mechanisms of action, and safety profile of noni fruit juice. Indication from in vitro, in vivo, and limited clinical studies suggests that noni juice exhibits promising pharmacological potential, primarily attributed to its rich content of iridoids, phenolic compounds, flavonoids, and polysaccharides. However, despite its widespread consumption, well-designed clinical trials remain limited, and concerns regarding hepatotoxicity and electrolyte imbalance warrant cautious use. This review highlights current knowledge gaps and emphasizes the need for standardized preparations and rigorous clinical validation.
KEYWORDS: Morinda citrifolia, Noni fruit juice, Antioxidant, Anti-inflammatory, Nutraceutical, Phytochemistry.
INTRODUCTION:
Medicinal plants and plant-derived products continue to play a pivotal role in healthcare systems worldwide, particularly in the prevention and management of chronic non-communicable diseases such as diabetes mellitus, cardiovascular disorders, cancer, and inflammatory conditions1. Among these, Morinda citrifolia L. (family Rubiaceae), commonly known as noni, Indian mulberry, or cheese fruit, has attracted considerable scientific and commercial interest2.
The fruit juice of M. citrifolia is widely consumed as a nutraceutical and functional beverage and is marketed globally for its purported health-promoting effects3.
Traditionally, noni has been used for more than two millennia in Polynesian, Southeast Asian, and Ayurvedic systems of medicine to treat a broad spectrum of ailments including infections, wounds, arthritis, gastrointestinal disturbances, hypertension, and metabolic disorders4. The fermented juice of the ripe fruit represents the most popular and commercially significant formulation due to its ease of consumption and perceived enhanced bioactivity. In recent decades, noni fruit juice has been extensively investigated for its antioxidant, anti-inflammatory, immunomodulatory, antimicrobial, cardioprotective, and anticancer activities5.
Diabetes mellitus, particularly type 2 diabetes mellitus (T2DM), represents a growing global health burden characterized by chronic hyperglycemia, insulin resistance, oxidative stress, inflammation, and progressive organ damage. Despite the availability of conventional antidiabetic drugs, long-term management remains challenging due to adverse effects, high costs, and limited efficacy in preventing complications. Consequently, there is increasing interest in identifying plant-based interventions that can target multiple pathological pathways involved in diabetes6.
Preclinical evidence suggests that noni fruit juice may influence glucose metabolism, lipid homeostasis, oxidative stress, and inflammatory signaling-key mechanisms underlying the development and progression of diabetes and its complications7,8. However, the available evidence remains fragmented, and comprehensive reviews integrating noni fruit juice biology with metabolic disease, particularly diabetes, are limited. Therefore, this review aims not only to summarize the phytochemical composition and biological activities of noni fruit juice but also to provide a clear scientific rationale for further research into its potential role in diabetes management.
Morinda citrifolia is a small evergreen tree or shrub, growing up to 8-10 m in height. It is native to Southeast Asia and Australasia but is now widely distributed throughout tropical and subtropical regions. The fruit is ovoid, fleshy, and yellowish-white when ripe, emitting a characteristic pungent odor. The fruit is commonly processed into juice through fermentation or mechanical pressing9.
Phytochemical analyses have revealed that noni fruit juice contains a diverse array of bioactive compounds, including:
· Iridoids: Deacetylasperulosidic acid, asperulosidic acid
· Phenolic compounds: Scopoletin, damnacanthal
· Flavonoids: Quercetin, kaempferol
· Organic acids: Caproic, caprylic acids
· Polysaccharides and glycosides
· Vitamins and minerals: Vitamin C, potassium
Iridoids are considered the major contributors to the antioxidant and anti-inflammatory effects of noni juice, while phenolic compounds contribute to antimicrobial and anticancer activities16.
Oxidative stress plays a central role in the pathogenesis of chronic diseases, including diabetes mellitus, by promoting β-cell dysfunction, insulin resistance, and vascular complications. Multiple in vitro assays, such as DPPH, ABTS, and FRAP, as well as in vivo studies, demonstrate that noni fruit juice exhibits significant free radical scavenging and metal-chelating activity. Consumption of noni juice has been associated with increased levels of endogenous antioxidant enzymes, including superoxide dismutase, catalase, and glutathione peroxidase, while simultaneously reducing lipid peroxidation markers such as malondialdehyde17-18.
The antioxidant capacity of noni fruit juice is largely attributed to its iridoids (deacetylasperulosidic acid and asperulosidic acid), phenolic acids, flavonoids, and vitamin C content. Given that oxidative stress is a major contributor to insulin resistance and diabetic complications, the antioxidant properties of noni juice provide a mechanistic basis for its potential antidiabetic effects19.
Chronic low-grade inflammation is a hallmark of type 2 diabetes and metabolic syndrome. Noni fruit juice has demonstrated the ability to suppress inflammatory mediators such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), nitric oxide, and cyclooxygenase-2 (COX-2) in experimental models. Animal studies have reported reduced paw edema, decreased inflammatory infiltration, and attenuation of pain perception following noni juice administration20.
These anti-inflammatory effects are particularly relevant to diabetes, as pro-inflammatory cytokines interfere with insulin signaling pathways and contribute to β-cell apoptosis. By modulating inflammatory cascades, noni fruit juice may help preserve insulin sensitivity and pancreatic function21.
Noni fruit juice has been shown to modulate both innate and adaptive immune responses. Studies indicate enhanced macrophage phagocytic activity, increased lymphocyte proliferation, and altered cytokine profiles following noni juice supplementation. While immune modulation is traditionally associated with infection and cancer, emerging evidence suggests that immune dysregulation also contributes to metabolic diseases, including diabetes22.
By influencing immune-inflammatory interactions, noni fruit juice may indirectly affect metabolic homeostasis and reduce inflammation-driven insulin resistance.
The antimicrobial activity of noni fruit juice has been documented against a range of Gram-positive and Gram-negative bacteria, as well as fungal species. This activity is mainly attributed to phenolic compounds, organic acids, and iridoids. Although antimicrobial effects are not directly related to diabetes, they may be beneficial in preventing infections, which are common complications in diabetic patients23.
Dyslipidemia is a frequent comorbidity in diabetes and significantly increases cardiovascular risk. Preclinical studies have shown that noni fruit juice can reduce total cholesterol, triglycerides, and low-density lipoprotein (LDL) levels while increasing high-density lipoprotein (HDL). Additionally, antihypertensive and vasoprotective effects have been reported, suggesting benefits for cardiovascular health24-25.
Improvement in lipid metabolism and vascular function is particularly important in diabetes management, as cardiovascular disease remains the leading cause of mortality among diabetic patients.
6. Anticancer Potential:
Several in vitro and animal studies indicate that noni fruit juice may exert anticancer effects through apoptosis induction, immune enhancement, and inhibition of angiogenesis. While these effects are beyond the scope of diabetes management, they demonstrate the broad pharmacological profile of noni juice and its ability to modulate multiple cellular pathways26.
Human studies on noni fruit juice are limited and often involve small sample sizes. Some trials report improvements in antioxidant status, physical endurance, and markers of inflammation, while others show minimal or no significant effects. Variability in juice preparation, dosage, and study design complicates interpretation of results27.
Noni fruit juice is generally considered safe when consumed in moderate amounts. However, isolated case reports of hepatotoxicity have been documented. The high potassium content may pose risks to individuals with renal impairment or those taking potassium-sparing medications. Standardization and quality control are critical to ensuring safety28.
Despite extensive preclinical research on noni fruit juice, several limitations restrict its translation into clinical practice. Many studies employ different preparation methods, fermentation times, dosages, and experimental models, resulting in variability and limited reproducibility. Furthermore, human clinical trials remain scarce, short-term, and often lack rigorous controls29.
From a Diabetes Research Perspective, Several Critical Gaps Remain:
1. Limited Direct Antidiabetic Evidence: While antioxidant, anti-inflammatory, and hypolipidemic effects of noni fruit juice are well documented, direct evaluation of its effects on fasting blood glucose, insulin sensitivity, glycated hemoglobin (HbA1c), and pancreatic β-cell preservation is limited30.
2. Mechanistic Understanding: The molecular mechanisms by which noni fruit juice may influence glucose transporters, insulin signaling pathways, hepatic gluconeogenesis, and gut microbiota remain largely unexplored31.
3. Dose Standardization and Bioavailability: There is a lack of standardized dosing regimens and insufficient data on the bioavailability and pharmacokinetics of key iridoids and phenolic compounds32.
4. Long-term Safety in Diabetic Populations: Given the chronic nature of diabetes, long-term safety studies are essential, particularly in populations with renal or hepatic impairment16.
The convergence of oxidative stress, inflammation, dyslipidemia, and immune dysfunction in diabetes provides a strong scientific rationale for further investigation of noni fruit juice as a complementary therapeutic agent. Future research should prioritize well-designed animal studies using diabetic models, followed by randomized controlled clinical trials assessing metabolic endpoints.
Noni (Morinda citrifolia) fruit juice possesses a wide range of biological activities supported primarily by preclinical studies. While traditional use and experimental data suggest significant health benefits, conclusive clinical evidence remains insufficient. Careful standardization, rigorous clinical trials, and safety monitoring are essential before noni juice can be recommended as a therapeutic agent.
1. Ansari P, Reberio AD, Ansari NJ, Kumar S, Khan JT, Chowdhury S, Abd El-Mordy FM, Hannan JMA, Flatt PR, Abdel-Wahab YHA, et al. Therapeutic Potential of Medicinal Plants and Their Phytoconstituents in Diabetes, Cancer, Infections, Cardiovascular Diseases, Inflammation and Gastrointestinal Disorders. Biomedicines. 2025; 13(2): 454.
2. Lin YL, Lin HW, Chen YC, Yang DJ, Li CC, Chang YY. Hepatoprotective effects of naturally fermented noni juice against thioacetamide-induced liver fibrosis in rats. Journal of the Chinese Medical Association. 2017; 80: 212-21.
3. West BJ, Isami F, Uwaya A, Jensen CJ. The Potential Health Benefits of Noni Juice: A Review of Human Intervention Studies. The Potential Health Benefits of Noni Juice: A Review of Human Intervention Studies. Foods. 2018; 7: 58-80.
4. Mohammad A, Mruthunjaya K, Manjula SN. Health Benefits of Morinda citrifolia (Noni): A Review. Pharmacognosy Journal. Jul-Aug 2016; 8(4): 321-34.
5. Fu X, Kim MH, Oh G, Im JH, Lim JS, Seong YS, Lee JY, Park EY, Lee DS, La IJ, Lee OH. Analysis of the Bioactive Compounds and Physiological Activities of Commonly Consumed Noni Juice in Republic of Korea. Foods. 2025 Oct 30;14(21):3732.
6. Gieroba B, Kryska A, Sroka-Bartnicka A. Type 2 diabetes mellitus - conventional therapies and future perspectives in innovative treatment. Biochem Biophys Rep. May 2025; 2(42):102037.
7. Zhang X, Zhang B, Li L, Li X, Zhang J, Chen G. Fermented noni (Morinda citrifolia L.) fruit juice improved oxidative stress and insulin resistance under the synergistic effect of Nrf2/ARE pathway and gut flora in db/db mice and HepG2 cells. Food Funct. 2022 Aug 1; 13(15): 8254-73.
8. Puranik DS, Mohammed F, Nagaraju B, Patan F, Nazeer A, Purohit S, Ali B. Preclinical evaluation of Antidiabetic activity of Noni Fruit Juice. International Journal of Bioassays. 2013; 2(2): 475-82.
9. Hou S, Ma D, Wu S, Hui Q, Hao Z. Morinda citrifolia L.: A Comprehensive Review on Phytochemistry, Pharmacological Effects, and Antioxidant Potential. Antioxidants (Basel). 2025 Feb 28; 14(3): 295.
10. Mahattanadul S, Ridtitid W, Nima S, Phdoongsombut N, Ratanasuwon P, Kasiwong S. Effects of Morinda citrifolia aqueous fruit extract and its biomarker scopoletin on reflux esophagitis and gastric ulcer in rats. Journal of Ethnopharmacology. .2011; 134(2): 243-50.
11. Sina H, Dramane G, Tchekounou P, Assogba MF, Chabi SK, Boya B, Socohou A, Adjanohoun A, Baba ML. Phytochemical composition and in vitro biological activities of Morinda citrifolia fruit juice. Saudi Journal of Biological Sciences. 2021; 28(2): 1331-5.
12. Wu T, Li M, Lan Z. Reveal the variation patterns of chemical composition in the fruit of Morinda citrifolia (noni) during postharvest storage through metabolomic characterization. Tropical Plant Biology.2019; 12: 85-97.
13. Singh DR, Singh S. Phytochemicals in plant parts of noni (Morinda citrifolia L.) with special reference to fatty acid profiles of seeds. Proceedings of the National Academy of Sciences, Inia Section B: Biological Sciences. 2013; 83: 471-8.
14. Thoo YY, Ho SK, Liang JY, Ho, CW, Tan CP. Effects of binary solvent extraction system, extraction time and extraction temperature on phenolic antioxidants and antioxidant capacity from mengkudu (Morinda citrifolia). Food Chemistry. 2010; 120(1): 290-5.
15. Yang J, Paulino R, Janke SS, Abawi F. Free-radical-scavenging activity and total phenols of noni (Morinda citrifolia L.) juice and powder in processing and storage. Food Chemistry. 2007; 102(1): 302-8.
16. Guo L, Qiao J, Huo J, Rupasinghe HPV. Plant iridoids: Chemistry, dietary sources and potential health benefits. Food Chem X. 2025 Apr 23; 27:102491.
17. Pitocco D, Tesauro M, Alessandro R, Ghirlanda G, Cardillo C. Oxidative stress in diabetes: implications for vascular and other complications. Int J Mol Sci. 2013 Oct 30; 14(11): 21525-50.
18. Chang YC, Chuang LM. The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication. Am J Transl Res. 2010 Jun 10;2(3):316-31.
19. Ma DL, Chen M, Su CX, West BJ. In vivo antioxidant activity of deacetylasperulosidic Acid in noni. J Anal Methods Chem. 2013; 2013: 804504.
20. Okdahl T, Wegeberg AM, Pociot F, Brock B, Størling J, Brock C. Low-grade inflammation in type 2 diabetes: a cross-sectional study from a Danish diabetes outpatient clinic. BMJ Open. 2022 Dec 14; 12(12): e062188.
21. Nerurkar PV, Hwang PW, Saksa E. Anti-Diabetic Potential of Noni: The Yin and the Yang. Molecules. 2015 Sep 25; 20(10): 17684-719.
22. Ezzat MI, Hassan M, Abdelhalim MA, El-Desoky AM, Mohamed SO, Ezzat SM. Immunomodulatory effect of Noni fruit and its isolates: insights into cell-mediated immune response and inhibition of LPS-induced THP-1 macrophage inflammation. Food Funct. 2021 Apr 7; 12(7): 3170-3179.
23. Bakal SN, Bereswill S, Heimesaat MM. Finding novel antibiotic substances from medicinal plants-Antimicrobial properties of Nigella sativa directed against multidrug-resistant bacteria. European Journal of Microbiology and Immunology. 2017; 7(1): 92-8.
24. Mandukhail SU, Aziz N, Gilani AH. Studies on antidyslipidemic effects of Morinda citrifolia (Noni) fruit, leaves and root extracts. Lipids Health Dis. 2010 Aug 20; 9:88.
25. Shoeb A, Alwar MC, Shenoy PJ, Gokul P. Effect of Morinda citrifolia (Noni) Fruit Juice on High Fat Diet Induced Dyslipidemia in Rats. J Clin Diagn Res. 2016 Apr; 10(4): FF06-10.
26. Chanthira Kumar H, Lim XY, Mohkiar FH, Suhaimi SN, Mohammad Shafie N, Chin Tan TY. Efficacy and Safety of Morinda citrifolia L. (Noni) as a Potential Anticancer Agent. Integr Cancer Ther. 2022 Jan-Dec; 21: 15347354221132848.
27. West BJ, Deng S, Isami F, Uwaya A, Jensen CJ. The Potential Health Benefits of Noni Juice: A Review of Human Intervention Studies. Foods. 2018 Apr 11; 7(4): 58.
28. Stadlbauer V, Fickert P, Lackner C, Schmerlaib J, Krisper P, Trauner M, Stauber RE. Hepatotoxicity of NONI juice: report of two cases. World J Gastroenterol. 2005 Aug 14;11(30):4758-60.
29. Puranik DS, Mohammed F, Nagaraju B, Patan F, Nazeer A, Purohit S, Buden RP. Studies on Hypoglycemic effect of Morinda Citrafolia.L Fruit Juice. Int. J. Biopharm.Nanomed. Sci, 2013; 2(1): 84-92.
30. Lee SY, Park SL, Hwang JT, Yi SH, Nam YD, Lim SI. Antidiabetic Effect of Morinda citrifolia (Noni) Fermented by Cheonggukjang in KK-A(y) Diabetic Mice. Evid Based Complement Alternat Med. 2012; 2012:163280.
31. genstaedt P, Stumpenhagen A, Westendorf J. The Effect of Morinda citrifolia L. Fruit Juice on the Blood Sugar Level and Other Serum Parameters in Patients with Diabetes Type 2. Evid Based Complement Alternat Med. 2018 Aug 6; 2018:3565427.
32. Inada AC, Silva GT, Silva LPRD, Alves FM, Filiú WFO, Asato MA, Junior WHK, Corsino J, Figueiredo PO, Garcez FR, Garcez WS, Silva RNOD, Santos-Eichler RAD, Guimarães RCA, Freitas KC, Hiane PA. Therapeutic Effects of Morinda citrifolia Linn. (Noni) Aqueous Fruit Extract on the Glucose and Lipid Metabolism in High-Fat/High-Fructose-Fed Swiss Mice. Nutrients. 2020 Nov 10; 12(11): 3439.
|
Received on 24.12.2025 Revised on 17.02.2026 Accepted on 24.03.2026 Published on 02.07.2026 Available online from July 15, 2026 Asian J. Res. Pharm. Sci. 2026; 16(3):307-310. DOI: 10.52711/2231-5659.2026.00045 ©Asian Pharma Press All Right Reserved
|
|
|
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License. |
|